Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

about

Trial watch: Immune checkpoint blockers for cancer therapy.Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.

P2860

Q47393365-D4FDD073-1251-410A-A1D9-389B707A867F Q51075769-817AB29E-255A-4A9B-8F8D-7CF3E7336EDC

P2860

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

Item

http://www.wikidata.org/entity/Q36597361

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

@ast

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

@en

type

Item

label

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

@ast

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

@en

prefLabel

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

@ast

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

@en

P1476

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

@en

P2093

Anika Beckers

http://www.w3.org/2001/XMLSchema#string

Anne Ruth Kesper

http://www.w3.org/2001/XMLSchema#string

Annkristin Heine

http://www.w3.org/2001/XMLSchema#string

Dominik Wolf

http://www.w3.org/2001/XMLSchema#string

Kathrin Schönberg

http://www.w3.org/2001/XMLSchema#string

Peter Brossart

http://www.w3.org/2001/XMLSchema#string

Stefanie Andrea Erika Held

http://www.w3.org/2001/XMLSchema#string

P2860

Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

Chronic myeloid leukemia.

The molecular biology of chronic myeloid leukaemia.

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia.

JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis.

Retroviral insertional mutagenesis identifies RUNX genes involved in chronic myeloid leukemia disease persistence under imatinib treatment

Imaging tumor-stroma interactions during chemotherapy reveals contributions of the microenvironment to resistance.

Effects of imatinib on normal hematopoiesis and immune activation.

P304

e1065368

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2015.1065368

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26942083

http://www.w3.org/2001/XMLSchema#string

P932

4760295

http://www.w3.org/2001/XMLSchema#string

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

about

P2860

P2860

Interferon gamma modulates sensitivity of CML cells to tyrosine kinase inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932